(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 23.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.52%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.17%.
Glaukos's revenue in 2026 is $551,349,000.On average, 16 Wall Street analysts forecast GKOS's revenue for 2026 to be $37,843,433,536, with the lowest GKOS revenue forecast at $35,974,520,488, and the highest GKOS revenue forecast at $39,673,582,202. On average, 16 Wall Street analysts forecast GKOS's revenue for 2027 to be $47,684,887,663, with the lowest GKOS revenue forecast at $41,667,011,142, and the highest GKOS revenue forecast at $51,802,134,824.
In 2028, GKOS is forecast to generate $61,435,670,906 in revenue, with the lowest revenue forecast at $47,889,281,673 and the highest revenue forecast at $71,420,435,776.